Skip to main content

Table 5 List of podocyte-associated proteins

From: Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy

Accession ID

NCBInr DB

Accession ID

GenBank DB

Protein name

Sequence coverage (%)

Peptide match (n)

PLA2R (+) pMN patients (n = 6)/Transplantation donors (n = 5) ratio (Ratio variability [%])

PLA2R (−) pMN patients (n = 6)/Transplantation donors (n = 5) ratio (Ratio variability [%])

BCL-induced sMN patients (n = 6)/Transplantation donors (n = 5) ratio (Ratio variability [%])

150170672

 

THSD7A

2

3

0.97 (83.71)

1.80 (80.92)

2.05 (92.14)

204306657

 

Nephrin

3

4

0.73 (60.28)

0.81 (61.73)

0.98 (38.71)

7657615

 

Podocin

9

3

1.59 (75.95)

1.82 (73.38)

2.55 (94.26)

1034591669

 

Zo-1

8

12

1.51 (78.11)

1.81 (68.22)

1.20 (78.79)

5453599

 

F-actin-capping protein α2

18

4

4.55 (62.71)

4.92 (65.91)

1.67 (72.65)

578810794

 

Synaptopodin

15

11

1.36 (69.45)

1.30 (61.22)

1.54 (66.93)

12025678

 

α-actinin-4

58

44

1.68 (100.17)

1.62 (95.46)

1.09 (91.42)

12667788

 

Myosin-9

11

19

1.87 (85.85)

1.87 (87.83)

1.15 (78.52)

219520307

BC143318.1

Podocalyxin

9

5

2.33 (86.65)

3.21 (79.78)

1.86 (97.71)

119615053

 

Integrin α3

6

6

0.85 (66.75)

1.01 (72.04)

1.35 (81.96)

76879682

 

Nestin

30

28

8.40 (95.45)

0.46 (136.13)

0.01**

62414289

 

Vimentin

80

59

3.10 (107.54)

2.48 (106.48)

1.23 (107.57)

  1. BCL: bucillamine; DB: data base; NCBInr: National Cancer for Biotechnology Information non-redundant; PLA2R: phospholipase A2 receptor; pMN: primary membranous nephropathy; sMN: secondary membranous nephropathy; THSD7A: thrombospondin type-1 domain-containing 7A; Zo-1: zonula occludens-1
  2. **P < 0.01